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ABSTRACT
Pre-mRNA splicing occurs in a large complex splic-
eosome. The steps of both spliceosome assembly
and splicing reaction have been extensively ana-
lyzed, and many of the factors involved have been
identified. However, the post-splicing intron turn-
over process, especially in vertebrates, remains to
be examined. In this paper, we developed a two-tag
affinity purification method for purifying lariat intron
RNA–protein complexes obtained from an in vitro
splicing reaction. Glycerol gradient sedimentation
analyses revealed that there are at least two forms
of post-splicing intron complexes, which we
named the ‘Intron Large (IL)’ and the ‘Intron Small
(IS)’ complexes. The IL complex contains U2, U5 and
U6 snRNAs and other protein splicing factors,
whereas the IS complex contains no such U
snRNAs or proteins. We also showed that TFIP11,
a human homolog of yeast Ntr1, is present in the
IL complex and the TFIP11 mutant protein, which
lacks the interaction domain with hPrp43 protein,
caused accumulation of the IL complex and reduc-
tion of IS complex formation in vitro. Taken
together, our results strongly suggest that TFIP11
in cooperation with hPrp43 mediates the transition
from the IL complex to the IS complex, leading to
efficient debranching and turnover of excised
introns.
INTRODUCTION
Nuclear pre-mRNA splicing takes place in a large RNA–
protein complex (RNP) that is termed ‘spliceosome’.
Spliceosome is composed of U1, U2, U4/U6 and U5
snRNPs and a large number of non-snRNP proteinaceous
splicing factors (1,2). Spliceosome assembly has been
extensively analyzed by in vitro splicing systems using
extracts from HeLa and Saccharomyces cerevisiae cells
(1). In both systems, spliceosome formation proceeds by
a sequential assembly of several intermediate complexes.
In mammals the intermediate complexes are termed H, E,
A, B, B
  and C (1).
In the ﬁrst step, the naked pre-mRNA associates with
heterogeneous nuclear ribonucleoproteins (hnRNPs),
which are abundant nuclear RNA-binding proteins, to
form the H complex. Then, U1 snRNP recognizes and
binds to a conserved 50 splice site in an ATP-independent
manner to give the E complex. Subsequently, U2 snRNP
stably binds to a branch point sequence in an ATP-depen-
dent manner forming the A complex. Then, preformed tri-
snRNP (U4/U6 and U5) joins the A complex giving rise to
the B complex. Subsequently, the B complex is activated
through RNP rearrangements leading to the displacement
or destabilization of U1 and U4 snRNPs from the spliceo-
some (3,4). The resultant B
  spliceosome, which is also
called the activated spliceosome, catalyzes the ﬁrst step
reaction, during which the branch-point adenosine attacks
the 50 splice site, generating a cleaved 50 exon and intron–
30 exon lariat intermediates (3). As a result of the above
reaction, the C1 complex is formed and mediates catalysis
of the second step of splicing via ATP hydrolysis (1,5).
This results in the formation of the C2 complex, which
contains ligated exons and excised lariat introns (6). C1
and C2 complexes are often collectively called the ‘C
complex’.
In addition to U snRNAs and their speciﬁc proteins, a
large number of non-snRNP proteins are associated with
spliceosome and play essential roles in splicing. In order to
learn about the dynamics of the spliceosome’s proteome,
mass spectrometric (MS) studies of the spliceosomal com-
plexes isolated at deﬁned stages have been performed (1).
The complexes analyzed to date include the H, A, BU1
(B complex lacking U1 snRNP), B, B
  and C1
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et al. (10) describes the puriﬁcation and characterization
of fully assembled, active spliceosome C1 complexes that
contain the products of the ﬁrst step of splicing and are
capable of carrying out the second-step reaction (exon
ligation) without additional protein factors. From these
MS analyses, over 100 splicing factors have been identi-
ﬁed, and their dynamic association and dissociation
during spliceosome formation have been uncovered.
Compared to the extensive analysis of the steps and
factors of spliceosome formation, little is known about
the post-splicing pathway. Only a few factors involved in
the post-splicing process have been identiﬁed, almost
exclusively by analyses of budding yeast mutants. Upon
the completion of the splicing reaction, the spliced RNA
(mRNA) is released from the spliceosome, and the
remaining post-splicing RNPs containing the lariat
intron are disassembled in an active process involving
two members of the ATP-dependent DExH box RNA
helicase family, Prp22 and Prp43 (13,14). Prp22 is
needed for the release of the spliced RNA (14), while
Prp43 is necessary for the disassembly of the remaining
intron-containing RNP (15,16). Recently it has been
shown that two splicing factors, Ntr1 and Ntr2, in the
form of a stable dimmer, associate with Prp43. The resul-
tant trimeric complex is termed the ‘NTR complex’ (17).
Ntr1 contains a G-patch domain at its N-terminal region,
which is responsible for its interaction with Prp43, and this
interaction stimulates Prp430s helicase activity in vitro
(17,18). The NTR complex is functional in catalyzing
the disassembly of the spliceosome (17). After dissociation
of U snRNPs and other splicing factors from the lariat
intron, the intron is linearized by a lariat intron debranch-
ing enzyme, DBR1, before being degraded (19).
In humans, most of the genes encoded in the nucleus
contain multiple introns, which occupy 95% of the
protein-coding primary transcripts (20,21). These introns
are excised from pre-mRNAs by splicing as a lariat form
and get degraded in the nucleus (19). If the excised introns
are not processed properly in the nucleus, the splicing
factors become trapped on the excised introns and the
splicing reaction is negatively aﬀected. The inhibition of
intron degradation into mononucleotides might cause a
reduction in the amount of free nucleotides, which could
result in transcription defects. Moreover, in vertebrates,
guide small nucleolar RNAs (snoRNAs), which mediate
ribosomal RNAs modiﬁcations, are encoded in the introns
of some genes. These snoRNAs are known to be processed
from the excised introns in coordination with the splicing
process (22). The loss of functional snoRNAs leads to
production of unmodiﬁed rRNAs, which reduces ribo-
some processivity. Therefore, it is likely that the post-
splicing intron turnover process is extremely important
in vertebrates.
Although no study has focused on the post-splicing
intron turnover process in mammals, the homologs of
the factors described above in yeast have been identiﬁed
in mammals. HRH1 (Human RNA Helicases 1), a human
homolog of yeast Prp22 protein, mediates the release of
spliced mRNA from the spliceosome (23,24). Homologs of
Prp43 have also been identiﬁed in mice and humans
(25,26). Moreover, human and mouse DBR1 proteins,
which show a high sequence homology to the yeast pro-
tein, were demonstrated to complement the yeast dbr
mutant (27,28). Recently it has been shown that human
Ntr1 like protein, which is also called Tuftelin Interacting
Protein 11 (TFIP11), interacts with factors involved in
DNA double-strand break repair and telomere metabo-
lism (29). However, the function of TFIP11 in splicing
has not been investigated. To date, no human homologs
of NTR2 have been reported.
In this report, we developed a puriﬁcation system for
excised intron RNPs obtained via in vitro splicing reac-
tions using two aﬃnity tags. Glycerol gradient sedimenta-
tion experiments revealed that there are two diﬀerent
forms of post-splicing intron complexes. One is a 40S
form with U2, U5 and U6 snRNPs, which was termed
the ‘IL (Intron Large) complex’, and the other is a 20S
form, which was termed the ‘IS (Intron Small) complex’.
We investigated the protein composition of these com-
plexes by MS and western blotting and found stable asso-
ciations of several human Prp19 complex factors with the
IL complex, but none with the IS complex. SF3a/3b pro-
teins, which are 17S U2 snRNP associated factors, did not
stably associate with the IL complex although U2 snRNA
and its speciﬁc protein U2B00 were present in the complex.
The IS complex contained none of the tested U snRNAs
and protein factors.
Furthermore, we found that the TFIP11/hNtr1 protein
is stably present in the IL complex and that it recruits
the hPrp43 protein to the IL complex through inter-
actions mediated by its N-terminal G-patch region.
Overexpression of the mutant TFIP11 protein, which
lacks the G-patch domain caused the accumulation of
IL complex and a reduction in IS complex formation.
We also demonstrated that the lariat intron in the IS com-
plex is more susceptible to debranching reaction by
hDBR1 than that in the IL complex. Our results strongly
suggest that the hPrp43–TFIP11 complex catalyzes the
transition of the IL complex to the IS complex leading
to eﬃcient debranching and subsequent degradation of




For the construction of the pd-crystallin MS2 plasmid, a
DNA fragment containing three copies of the MS2 bind-
ing site was generated as described previously (30)
although we attached SacI sites at both ends of the frag-
ment. One copy of this fragment was inserted into the SacI
site between the 50 splice site and the branch adenosine of
the pSP14-15 plasmid (23). For the construction of the
pAd2-MS2 plasmid, three copies of the DNA fragment
that contained the SacII site at both ends were inserted
into the SacII site of the pAd2 plasmid (31). To prepare
plasmids for expressing Flag-tagged proteins in HEK293T
cells, full-length TFIP11 and hDBR1 cDNAs were ampli-
ﬁed by the PCR reaction from the Marathon ready
HeLa cDNA library (Clontech) and were cloned into the
892 Nucleic Acids Research, 2009, Vol. 37,No. 3EcoRI/XhoI sites and BamHI/XhoI sites of the Flag-
pCDNA3 (32), respectively. hDBR1 mutant cDNA
(NA) containing a point mutation in its GNHE motif
(33) was also prepared by PCR-based mutagenesis using
Flag-hDBR1 plasmid as a template. The oligonucleotides
used for this mutagenesis were as follows: forward primer:
50-ATGGGCTCCCCCAATGAAGAGCGT-30, reverse
primer: 50-GAAGCCTCAAATCATTTGCAAGAG-30.
TFIP11 mutant cDNA (N50) was also prepared by
PCR ampliﬁcation using speciﬁc primers (forward
primer: 50-AAAGAATTCCCAAGATGGGCTACGTCC
CTGGACGGG-30 and reverse primer: 50-AAACTCGAG
TCACTTGGCCATGTCGATCAGGCTC-30) and the
Flag-TFIP11 plasmid as a template.
For production of GST-MS2 and GST-hDBR1 protein
expression plasmids, PCR-ampliﬁed MS2 and hDBR1
cDNAs were inserted between the BamHI and XhoI
sites of pGEX6P-1 (GE Healthcare).
For the construction of a His-hPrp43 protein expression
plasmid, hPrp43 cDNA, a gift from Dr. Akila Mayeda,
was inserted between the NcoI and NotI sites of the
pFastBAC HTB plasmid (Invitrogen).
In vitro transcription, splicing and MS2 affinity purification
of intronRNP
The in vitro transcription reaction was usually performed
at 378C for 120min using MEGAscript (Ambion) accord-
ing to the manufacturer’s instructions. The preparation
of immobilized pre-mRNA containing a biotin-labeled
tag was performed as described previously (34).
Brieﬂy, 1 pmol of biotinylated pre-mRNA was incubated
with 10ml of Dynabeads m-280 magnetic streptavidin
beads (Invitrogen) in 20ml of IP1000 buﬀer [20mM
HEPES-NaOH (pH 7.9), 1000mM KCl and 0.05%
Triton X-100]. Prior to the splicing assay, the immobil-
ized substrate beads were washed twice with 400ml
IP1000 buﬀer and then with IP150 buﬀer [20mM
HEPES-NaOH (pH 7.9), 150mM KCl and 0.05%
Triton X-100].
The tethered pre-mRNA was then bound to 1.5mgo f
GST-MS2 protein and was incubated with 100ml of HeLa
cell nuclear extracts under splicing conditions (23). The
reaction mixture was incubated for 80min at 308C while
being rocked for 10s every 10min using Thermomixer
comfort (Eppendorf). After incubation, the resin was pre-
cipitated using a magnetic stand to recover the superna-
tant. Heparin (Sigma) was then added to a ﬁnal
concentration of 0.5mg/ml, and the resultant mixture was
further incubated for 5min at 308C. Next, the mixture was
incubated with 20ml of glutathione beads for 1h at
48C with rotating, being washed four times with
500ml IP150 buﬀer and subsequently eluted with elution
buﬀer (20mM HEPES-KOH pH7.9, 100mM KCl, 0.6%
sarkosyl, 10% glycerol, 0.1% NP-40, 0.1m EDTA and
1mM DTT). For the glycerol sedimentations assays,
the supernatant of the biotin-precipitated splicing mixture
was subjected to 10–30% glycerol gradient solution
(20mM HEPES-KOH pH7.9, 50mM KCl, 1.5mM
MgCl2, 1mM DTT and 10–30% glycerol) and was centri-
fuged at 40000r.p.m. for 3h with an SW41 rotor
(Beckman-Coulter). The fractions were recovered using a
Biocomp gradient station (Biocomp).
Antibodies and western blotting
The antibodies used for western blotting are listed below,
and they were obtained from the companies shown in
parentheses. Anti-Flag M2 antibody (SIGMA); anti-
hPrp19, hPrp43 and U5-116k (Bethyl Laboratories,
Inc.); anti- Xab2 (GENETYX); anti-U5-220k (Santa
Cruz); anti-SF3b130 and SF3a60 (Abcam); anti-U2B00
(PROGEN); anti-SF3b155 (MBL); and SF3a120
(Synaptic Systems). The antibody against IBP160 was a
kind gift from Dr. Tetsuro Hirose. The anti-TFIP11 anti-
body was kindly provided by Dr. Michael Paine. The anti-
hPrp43 antibody was a generous gift from Dr. Reinhard
Luhrmann. The anti-hDBR1 antibody was prepared by
immunizing two rabbits with GST-tagged hDBR1.
Immunization and preparation of antisera were performed
by SIGMA.
Western blotting was carried out as described pre-
viously (31) except that we used ECL and ECL advance
systems (GE Healthcare) for the detection. The signals
were obtained and analyzed by a LAS3000mini (Fuji
Film, Japan).
Northern blotting analysis
RNA samples were separated by denaturing polyacryla-
mide gel electrophoresis (PAGE) and were transferred to
hybond N
+ membranes (GE Healthcare). The oligonu-
cleotides used to prepare probes for U1, U2, U4, U5
and U6 snRNAs are described elsewhere (35). The prepa-
ration of [
32P]-labeled oligonucleotide probes was carried
out with T4 polynucleotide kinase (TOYOBO) as the
manufacturer recommends. Hybridization with oligonu-
cleotide DNA probes was performed in PERFECTHYB
PLUS (Sigma).
Invitro protein-binding experiments
The TFIP11 and TFIP11N proteins were produced
by in vitro transcription–translation using a TNT kit
(Promega) in rabbit reticulocyte lysate in the presence of
[
35S]-methionine (GE Healthcare) according to the manu-
facturer’s instructions. One microgram each of puriﬁed
His-GST and His-hPrp43 proteins were immobilized on
20ml Ni–NTA beads (Qiagen) in PBS for 1h at 48C.
The resin was washed with 500ml of binding buﬀer
(20mM Tris–HCl pH 7.5, 100mM NaCl, 0.1% NP-40
and 20mM Imidazole). The in vitro translated products
were added and incubated with these immobilized proteins
at 48C for 1 hour. After binding, the beads were washed
with 500ml of binding buﬀer ﬁve times, and the bound
fraction was analyzed by SDS–PAGE and visualized by
ﬂuorography.
Mass-spectrometric analysis
Mass-spectrometric identiﬁcation of proteins was per-
formed as previously described (36). Brieﬂy, after SDS–
PAGE, the proteins were visualized by silver staining and
excised separately from gels, followed by in-gel digestion
Nucleic AcidsResearch, 2009, Vol.37,No. 3 893with trypsin (Promega) in a buﬀer containing 50mM
ammonium bicarbonate (pH 8.0) and 2% acetonitrile
overnight at 378C. Molecular mass analyses of
tryptic peptides were performed by matrix-assisted laser
desorption/ionization time-of-ﬂight mass spectrometry
(MALDI-TOF/MS) using an Ultraﬂex TOF/TOF
(Bruker Daltonics). Proteins were identiﬁed by comparing
the molecular weights determined by MALDI-TOF/MS
and the theoretical peptide masses of proteins registered
in the NCBInr.
Immunoprecipitation ofRNAs and proteins
For immunoprecipitaion of RNA from the in vitro splicing
reaction, 1mg of anti-hPrp43 antibody (Bethyl), 1mg
of anti-GST antibody (Nakalai Tesque) for mock precip-
itation or 1mg of anti-Flag M2 (Sigma) were bound
to Protein A-Sepharose beads (GE Healthcare) on a
rotating platform for 1h at 48C. After the in vitro splicing
reaction, the mixture was diluted by a factor of 10 with
IP150 buﬀer, centrifuged at 14000 r.p.m. for 15min at
48C, and the resultant supernatant was used for incuba-
tion with the antibody-bound beads for 1h at 48C.
After the precipitation, the beads were washed ﬁve
times with 400ml of IP150 buﬀer and incubated in
100ml of HomoMix (50mM Tris at pH 7.4, 5mM
EDTA, 1.5% SDS, 300mM NaCl and 1.5mg/ml
Proteinase K) for 30min at 508C to elute RNA. Eluted
RNAs were extracted with phenol/chloroform and preci-
pitated by ethanol precipitation. The recovered RNAs
were analyzed by 6% denaturing PAGE.
For immunoprecipitation of Flag-tagged proteins,
nuclear extract from HEK293T cells that were tran-
siently expressing Flag-tagged proteins was prepared
(37), and the reaction mixture was incubated with
15ml of M2 aﬃnity agarose (Sigma). The beads were
washed ﬁve times with 400ml of IP150 buﬀer and
eluted with SDS sample buﬀer. The eluted proteins
were analyzed by 12% SDS–PAGE. RNase A (Nakalai
Tesque, Japan) was added to a ﬁnal concentration of
1mg/ml.
Recombinant proteinpreparation
GST-MS2 protein was overexpressed in Escherichia coli
BL21 (DE3) codonplus cells (Stratagene). Induction was
carried out at 208C overnight. Proteins were puriﬁed
according to the manufacturer’s instructions, and the
eluate was then puriﬁed with a Mono-Q column
(GE Healthcare).
For His-hPrp43 protein, the generation of recombinant
bacmids, their transfection into Sf9 cells and puriﬁcation
of his-tagged proteins were performed according to the
manufacturer’s instructions.
For Flag-tagged proteins, whole-cell lysates from
HEK293T cells were prepared from transfected cells as
previously described (38). Flag-tagged proteins were puri-
ﬁed from whole-cell lysates by using anti Flag-M2 aﬃnity
resin (SIGMA) as described previously (39).
RESULTS
The development of anintron RNP purification system from
in vitro splicing reaction mixture
In order to analyze the post-splicing intron turnover path-
way, attempts were made to isolate the post-splicing
intron complex from the in vitro splicing reaction. We
employed a two-aﬃnity tag puriﬁcation method
(Figure 1A). As the ﬁrst aﬃnity-tag, we used biotin resi-
dues. Biotin-labeled oligo DNA was ligated directly onto
the 30 end of a pre-mRNA derived from chicken d-crystal-
lin gene by the use of T4 DNA ligase as described pre-
viously (34). This pre-mRNA also contained three copies
of phage MS2 coat protein-binding sites in its intron. The
pre-mRNA was tethered to streptavidin magnetic beads
and then bound to GST-MS2 protein. The tethered pre-
mRNA was incubated with HeLa cell nuclear extracts
under splicing conditions, and the beads were precipitated
after the incubation. Since pre-mRNA, mRNA and lariat
intermediates all contain biotin residues in their 30 regions,
these RNAs were expected to remain bound to the beads.
The 50exon RNA should also be precipitated with the
beads through its interaction with the lariat intermediate
in the spliceosome (34). Therefore, only the lariat intron
that had been released from the spliceosome was antici-
pated to be in the supernatant (Figure 1A). The intron
complex in the supernatant was further puriﬁed by a
pull-down assay with glutathione beads.
The RNA products in each isolation step were analyzed
by denaturing PAGE (Figure 1B). The immobilized pre-
mRNA was spliced eﬃciently, and the majority of the
splicing products were bound to the beads (Figure 1B,
lane 2). In contrast, only lariat intron RNA was detected
in the supernatant fraction (lane 3). This lariat RNA was
eﬃciently recovered with glutathione beads (lane 4, about
15% was recovered).
We next analyzed the composition of U snRNAs in this
puriﬁed fraction. Northern blotting analysis using probes
against ﬁve spliceosomal U snRNAs revealed that U2, U5
and U6 snRNAs were present in much higher concentra-
tions in the post-splicing intron complex than in the con-
trol fraction, which was prepared without the addition
of exogenous pre-mRNA (Figure 1C, compare lanes 2
and 3). On the other hand, the levels of U1 and U4
snRNAs in this complex were not higher than those of
the control (Figure 1C, lanes 2 and 3). These results are
consistent with previous results showing that U1 and U4
snRNPs are not stably associated with late spliceosomes
(40). We also employed Adenovirus Major Late (AdML)
pre-mRNA (31) in the same system and obtained very
similar results (data not shown). Due to these results, we
concluded that our method was capable of purifying the
post-splicing intron complex that is produced by the
in vitro splicing reaction.
Identification ofthe twoforms of lariat–intronRNPs by
glycerol densitygradientsedimentation analysis
We further analyzed the post-splicing intron complex by
glycerol gradient sedimentation. The supernatant of the
streptavidin beads precipitation (the same fraction as in
894 Nucleic Acids Research, 2009, Vol. 37,No. 3Figure 1B, lane 3) was subjected to glycerol gradient cen-
trifugation, and the distribution of the lariat intron across
the gradient was analyzed. The results demonstrated that
there were at least two peak fractions for the lariat intron
(Figure 2A, lanes 4 and 8). The lighter fraction was about
20S, while the heavier fractions was 40S. A lariat intron
lacking its 30 tail was mainly detected in the lighter frac-
tion. These results suggested that two diﬀerent complexes
containing lariat RNA were present in the supernatant of
the streptavidin beads precipitation. We designated the
two complexes IL and IS complexes.
To analyze the composition of the two intron com-
plexes, aﬃnity-selection with glutathione beads was
performed with each gradient fraction, and bound
intron–RNPs were recovered (Figure 2B). For unknown
reasons, the lariat intron RNA was most eﬃciently recov-
ered from the ﬁfth fraction (Figure 2B, lane 5). The
eﬃciency of GST-MS2 pull down could have been aﬀected
by multiple factors. The complex in the ﬁfth fraction
might have been more accessible or more stably bound
by GST-MS2 protein than that in the fourth fraction.
This might mean that two types of complexes exist in
fractions 4–6.
Northern blotting analysis revealed that U2, U5 and U6
snRNAs were more concentrated in the IL complex frac-
tions, than in the control fractions (compare Figure 2C
with D). On the other hand, the IS complex contained
no such U snRNAs. Instead, the IS complex contained
some U1 snRNA (Figure 2C, lane 5). However, U1
cannot be a general component of the IS complex since
U1 snRNA was not detected in the IS complex when
we employed the AdML-MS2 pre-mRNA substrate
(Figure S1). Taken together, these results indicate that
there were at least two diﬀerent post-splicing intron com-
plexes in the released supernatant fraction. The heavier IL
complex is about 40S and contains U2, U5 and U6
snRNAs, whereas the smaller IS complex is about 20S
and is free of spliceosomal U snRNAs.
Identification of proteinfactors inthe lariat–intronRNPs
To obtain information regarding the protein composition
of the human intron complexes, proteins in the aﬃnity-
puriﬁed intron complex fraction were separated by SDS–
PAGE (Figure 3A, ‘lariat’ lane). Note that the glycerol
gradient separation procedure was not employed in this
experiment. As a control, gel-puriﬁed linear intron RNA
was incubated with HeLa nuclear extracts, and the iden-
tical aﬃnity selection procedures were performed
(Figure 3A, ‘control’ lane). By using this control RNA,
we should be able to recognize proteins that bind to
the intronic RNA sequence without splicing reaction.
Figure 1. Puriﬁcation of the post-splicing intron complex from an in vitro splicing reaction. (A) A schematic representation of the isolation of the
intron RNP complex from splicing reaction mixture. Chicken c-crystallin splicing substrate with three MS2 binding loops in its intron (d-3MS2) was
ligated with an oligonucleotide DNA containing biotinylated linker before being immobilized on streptavidin magnetic beads and bound with
recombinant GST-MS2 proteins. After immobilization, this pre-mRNA was spliced in HeLa cell nuclear extracts. The reaction was subjected to
precipitation using a magnetic stand to remove the pre-mRNA, splicing intermediates and mRNA. The supernatant was subjected to glutathione
beads to purify the intron-RNP, which was then eluted with Sarkosyl-containing elution buﬀer. (B) Analysis of the RNAs recovered from each step
of the intron–RNP puriﬁcation shown in (A). The RNAs were analyzed by 6% denaturing polyacrylamide gel electrophoresis. The structure
of each RNA is schematically shown on the right side of the panel. (C) Northern blotting analysis of the spliceosomal U snRNAs in the isolated
intron–RNP. HeLa cell nuclear extracts (HNE; lane 1) that contained all ﬁve U snRNAs were used as a positive control. The isolated intron–
RNPs with (lane 3) or without (lane 2) exogenously added pre-mRNAs were subjected to northern blotting analysis and probed for the ﬁve U
snRNAs.
Nucleic AcidsResearch, 2009, Vol.37,No. 3 895Proteins that bind to the lariat–intron through splicing
reaction would be anticipated to be enriched in the
lariat–intron complex as compared to the linear-intron
complex. The protein bands that appeared to be enriched
in the ‘lariat’ lane were excised from the gel and analyzed
by MS (Figure 3A). Several splicing factors, such as U2
and U5 snRNP speciﬁc proteins (SF3b130, U5-116K),
hPrp19 complex proteins (IBP160, Xab2, and hPrp19),
hPrp43 and some hnRNP proteins (hnRNP A2/B1,
I and U) as well as other proteins, were identiﬁed
(Figure 3A). Among the identiﬁed proteins, Tuftelin
interacting protein 11 (TFIP11) and hMtr4 (also known
Figure 2. Identiﬁcation of the two major intron-RNPs. (A) Glycerol
gradient fractionation (10–30%) of the supernatant of the streptavidin
agarose pull-down assay as in Figure 1. The total lane contained 10%
of the supernatant before sedimentation. The RNAs from each fraction
were recovered and analyzed by 6% denaturing polyacrylamide gel
electrophoresis. The fractions that human 17S U2 snRNP, yeast 40S
and 60S ribosome migrated to are shown at the top. (B) MS2 aﬃnity
puriﬁcation of intron–RNPs from each fraction. The RNPs were pre-
cipitated by glutathione beads through the GST-MS2 binding. The
recovered RNAs were analyzed as in (A). The positions of two
intron RNA peaks are indicated above as IS and IL. The structure
of each RNA is shown on the left of the panel. The lane marked as
total contained 10% of the supernatant before sedimentation.
(C) Northern blotting analysis of spliceosomal U snRNAs in each
glutathione beads puriﬁed fraction. The total lane contained a glu-
tathione puriﬁed fraction from 10% of the supernatant before sedimen-
tation. (D) Northern blotting analysis of glutathione aﬃnity-puriﬁed
fractions from a control experiment under the same conditions as
(C) except for the absence of pre-mRNA. The exposure time of this
membrane to the X-ray ﬁlm was the same as in (C).
Figure 3. Proteins associated with puriﬁed intron-RNP. (A) The protein
composition of GST-MS2 aﬃnity-puriﬁed intron mRNPs. Proteins
from the entire eluate were separated by 10% SDS–PAGE and stained
with silver. A subset of the proteins that were concentrated in the lariat
intron complex (lane 3) and identiﬁed by MS is indicated on the
right. Lane 1: molecular weight markers; lane 2: control pull-down
experiment performed with an in vitro transcribed linear intron in the
presence of GST-MS2. (B) Characterization of puriﬁed intron RNPs by
western blotting analysis. Intron complexes were separated as in
Figure 2, and proteins were subsequently separated by a 5–20%
SDS–PAGE gradient, blotted on a PVDF membrane and probed
with several antibodies against the proteins shown on the left.
The fractions that IS and IL complexes were mainly fractionated into
are indicated at the top. HeLa cell nuclear extracts were used as a
control (a lane marked HNE). The total lanes contain the
supernatant of the MS2 puriﬁcation step prepared with (+) or without
(–) pre-mRNA.
896 Nucleic Acids Research, 2009, Vol. 37,No. 3as fSAP118) were reported to be present in the spliceo-
some (1,41), but their roles in splicing have not been clar-
iﬁed. The aﬃnity-puriﬁed fraction that was used for the
MS analysis should be a mixture of the IL and IS com-
plexes since the glycerol gradient separation procedure
was not employed.
In order to conﬁrm that the identiﬁed proteins are
indeed associated with post-splicing intron complexes,
western blotting analyses were performed using antibodies
against some of the identiﬁed proteins. The in vitro splic-
ing reaction was carried out with either d-MS2 (Figure 3B)
or AdML-MS2 (Figure S1B) pre-mRNA and the released
lariat–intron complexes (supernatant) were separated by
glycerol gradient sedimentation. Subsequently, aﬃnity
selection by glutathione beads was performed for each
glycerol gradient fraction, and the aﬃnity-selected frac-
tions were used for the western blotting analyses. The
results indicate that hPrp19 complex proteins such as
hPrp19, Xab2 and IBP160 are present in the IL complex.
U5 snRNP speciﬁc proteins such as U5-220k and
U5-116k, and U2 snRNP core protein U2B00 were also
found in the IL complex fraction. This is consistent with
the result in Figure 2B, which shows the presence of U2
and U5 snRNAs in the IL complex. On the other hand, no
components of the SF3a/3b complex were stably detected
in the IL complex (Figure 3B, SF3b155 and 130, SF3a120
and 60), although SF3b130 was identiﬁed by MS analysis
(Figure 3A). This suggests that the SF3a/3b complex has
dissociated prior to IL complex formation (see
‘Discussion’ section). TFIP11 was also detected in the IL
complex but not in the IS complex (Figure 3B and
Figure S1B). However, the signals of hPrp43 near the IL
and IS fractions and of SF3b155 and SF3b130 near the IS
fraction were also observed in the control fractions, in
which the same procedures were performed in the absence
of tagged pre-mRNA (data not shown, see also
Figure S1C). Thus, these signals could represent contam-
ination of endogenous complexes unrelated to the IL and
IS complexes. It should be pointed out, however, that
hPrp43 was detected by the MS analysis (Figure 3A).
hPrp43 interacts with TFIP11 and is likely to be targeted
transiently at the IL complex as will be shown and dis-
cussed later. The hDBR1 protein, which catalyzes the deb-
ranching reaction of the lariat intron, was not detected in
either complex. These results demonstrate that many of
the proteins identiﬁed by MS analysis of the lariat–
intron complex are associated with the IL complex,
whereas the IS complex does not contain any of the spli-
ceosomal U snRNAs or protein factors tested so far.
TFIP11 protein binds specifically tohPrp43 proteinand
mediates the disassembly ofintron RNP in cooperation with
hPrp43 protein
TFIP11, which was identiﬁed by MS analysis of the intron
complex, was found both in the spliceosome (1,10) and in
the IL complex (this study, Figure 3). Since this protein
shares relatively high homology (22% identity) with yeast
Ntr1 protein and was shown to be able to complement
the yeast ntr1 mutant strain (29), TFIP11 is considered
to be a human homolog of yeast Ntr1. The Ntr1 protein
associates with Prp43 protein and mediates the disassem-
bly of lariat–intron RNP into U snRNPs and the lariat
intron in yeast (17). Therefore using a co-immunoprecipi-
tation experiment, we tested if TFIP11 binds speciﬁcally to
hPrp43. We transiently expressed Flag-tagged TFIP11 in
HEK293T cells and carried out immunoprecipitations
with anti-Flag antibody from the whole-cell lysates of
the transfected cells. Endogenous hPrp43 protein was eﬃ-
ciently co-precipitated with Flag-TFIP11 (Figure 4A,
lane 4). This co-precipitation was not aﬀected by the pres-
ence of RNase A (Figure 4A, lane 5), suggesting
that TFIP11 and hPrp43 interact with each other through
protein–protein interactions. In yeast cells, Ntr1 interacts
with Prp43 through one of its domains called a G-patch
(17,18). Since TFIP11 also has a G-patch domain at its
amino-terminal region, we next sought to determine
whether the G-patch domain of TFIP11 is involved in
the interaction with hPrp43. We carried out in vitro bind-
ing assays with histidine (His)-tagged recombinant hPrp43
and [
35S]methionine-labeled, in vitro translated TFIP11
wild-type and mutant proteins (Figure 4B). The TFIP11
wild type bound eﬃciently to hPrp43 but not to the con-
trol protein His-GST (lanes 1–3). When the ﬁrst 50 amino
acids of TFIP11, which correspond to the ﬁrst half of the
G-patch domain, were deleted, the resultant mutant pro-
tein, termed TFIP11N, was no longer able to bind to
hPrp43 (lanes 4–6). These results strongly suggest that
TFIP11 interacts with hPrp43 through the G-patch
domain.In analogy with the yeast system, it was plausible
to hypothesize that TFIP11 mediates dissociation of U
snRNPs and other proteins from the IL complex through
its binding to hPrp43, prior to debranching of the lariat
intron. To test this hypothesis, we used the TFIP11N
protein, which lacks hPrp43-binding domain, since we
could expect that it would act as a dominant negative
protein. Wild-type or N mutant of TFIP11 was tran-
siently expressed in HEK293T cells by transfection
(Figure 5A). Nuclear extracts were prepared from the
transfected cells, and in vitro splicing was performed
using those extracts with d-crystallin pre-mRNA as a sub-
strate. When the extract from Flag-TFIP11-expressing
HEK293T cells was used, the lariat intron product was
most abundantly found in glycerol gradient fractions 4
and 5,which corresponded to the IS complex, but was
less present in fractions 8 and 9, which corresponded to
the IL complex (Figure 5B, left panel). In contrast,
when the nuclear extract from the HEK293T cells that
expressed Flag-TFIP11N was used, the lariat intron
product in the IS fractions was reduced and that in the
IL fractions was increased, suggesting that the IL complex
is a precursor of the IS complex and that the transition
from IL to IS complexes is slow in this extract (Figure 5B,
compare the right and left panels). We also carried
out immunoprecipitation assays with anti-Flag tag anti-
body using the fractionated IL containing complex to
examine the association of Flag-tagged TFIP11 proteins
with lariat RNA. The results showed that both
TFIP11N and the wild-type TFIP11 proteins could co-
precipitate with the lariat intron (Figure 5C, lanes 8 and
12, and 5D for quantiﬁcation). We also used anti-hPrp43
antibody for immunoprecipitation experiments and
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RNA from TFIP11N expressing extract was reproduci-
bly lower than that from the wild-type TFIP11 expressing
extract (Figure 5C, lanes 7 and 11, and 5D for quantiﬁca-
tion), suggesting that hPrp43 is recruited to the intron
complex through its interaction with the G-patch
domain of TFIP11. These results, taken together, strongly
suggest that the TFIP11 protein, in cooperation with
hPrp43, mediates the disassembly of the IL complex into
IS complex.
The differentsensitivities oflariat intronRNAs in IL and IS
complexes to debranching activity
The results so far suggest that the two identiﬁed intron
complexes are intermediate complexes of the post-splicing
intron degradation pathway. It was expected that the
lariat intron in the IS complex would be more susceptible
to the debranching reaction than that in the IL complex,
since U snRNPs and many proteins had already been
removed. To test this hypothesis, we carried out an
in vitro debranching assay with the two intron complex
fractions. For this assay, recombinant Flag-hDBR1 pro-
teins were expressed in HEK293T cells and puriﬁed
through an anti-Flag M2 antibody column. In addition
to the wild-type protein, a mutant hDBR1 protein,
which had a substitution at amino-acid residue 84 from
asparagine to alanine (N84A), was also prepared
(Figure 6A). The equivalent mutation in yeast Dbr1 pro-
tein had already been demonstrated to cause the loss of
debranching activity (33). When the recombinant
wild-type hDBR1 protein was incubated with the intron
RNPs immobilized on glutathione beads that were recov-
ered from the supernatant of streptavidin agarose precip-
itation as in Figure 1B, lane 4, a fraction of the lariat
intron was debranched and linearized (Figure 6B,
lane 3). On the other hand, neither the mock-puriﬁed
hDBR1 fraction nor the N84A mutant could cause the
debranching of the lariat intron (Figure 6B, lanes 2 and
4). These results indicate that the recombinant Flag-
hDBR1 protein has a debranching activity and that the
point mutation at N 84 to A caused the loss of this activ-
ity. When aﬃnity puriﬁed IL and IS complexes on glu-
tathione beads were incubated with the hDBR1 proteins,
the lariat intron in the IS complex was eﬃciently
debranched only by the wild-type hDBR1, while the
intron in the IL was quite resistant to debranching by
the wild-type hDBR1 (Figure 6B, compare lanes 7 and
11). These results demonstrate that the lariat intron in
the IS complex, which contains less factors, is more acces-
sible to hDBR1 for its debranching activity. In the IL
complex, it is likely that U snRNPs and other proteins
identiﬁed by MS protect the branch point region of the
lariat intron from hDBR1. In summary, our results
strongly suggest that the IL and IS complexes are inter-
mediate complexes of post-splicing intron degradation
and that the TFIP11–hPrp43 complex mediates the tran-
sition of the IL complex to the IS complex before the
debranching reaction by hDBR1.
Figure 4. The TFIP11 protein binds to hPrp43 through its amino-terminus. (A) In vivo association of hPrp43 with TFIP11. Immunoprecipitation
experiments were performed using anti-Flag M2 agarose from HEK293T whole-cell extracts transfected with either Flag-vector or Flag-TFIP11
and subjected to western blot analyses. The lane marked as ‘I’ contains 10% of the precipitated proteins. (B) The ﬁrst 50 amino acids of
TFIP11 are required for its binding to hPrp43 in vitro. Puriﬁed His-GST and His-hPrp43 proteins were immobilized on Ni-NTA beads and incubated
with in vitro translated
35S-labeled Flag-TFIP11 wild-type or N mutant protein. Bound proteins were eluted with SDS–
containing sample buﬀer, resolved by 12% SDS–PAGE and detected by autoradiography. An aliquot equivalent to 10% of the Flag-TFIP11
wild-type and N mutant proteins used for binding was run in the lane marked ‘Input’. Molecular mass markers are indicated on the left side
of the panel.
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In this study we have established a puriﬁcation method for
the post-splicing lariat intron complex using a two-tag
system (Figure 1A). By combining the puriﬁcation
method with glycerol gradient sedimentation analysis,
we have found that the excised lariat intron is present in
at least two diﬀerent forms, namely IL ( 40S) and IS
( 20S) complexes (Figure 2). The IL complex contains,
besides the excised lariat intron, U2, U5 and U6 snRNPs
and many protein factors including hPrp19 complex pro-
teins (hPrp19, Xab2, IBP160) and TFIP11, while the IS
complex contains no such U snRNPs or proteins. Our
results also suggest that the IL complex is a precursor of
the IS complex (Figure 5B). Thus, during the transition
from the IL to the IS complexes, all three spliceosomal U
snRNAs and many protein factors are dissociated from
the IL complex. It is likely from our results that a complex
containing TFIP11 and hPrp43 mediates this dissociation.
However, how this dissociation process is achieved is not
known.
It was reported that U5 snRNP is subjected to drastic
remodeling during spliceosome activation and is possibly
released after splicing as a form of 35S U5 snRNP
Figure 5. The amino terminus of TFIP11 is required for the transition from the IL complex to the IS complex in vitro.( A) Western blotting of the
extracts from the cells transfected with control plasmid (Vec), Flag-TFIP11 wild type (WT), or Flag-TFIP11 N mutant (N). The TFIP11 proteins
were detected using a monoclonal antibody against Flag. Molecular mass markers are shown on the left. (B)A nin vitro splicing reaction with
chicken d-crystallin pre-mRNA was carried out with nuclear extracts prepared from HEK293T cells expressing either the wild-type or N mutant of
Flag-TFIP11 proteins. The supernatant of the streptavidin agarose pull-down assay shown in Figure 1 was separated by 10–30% glycerol gradient.
The RNAs in each fraction were recovered and analyzed by 6% denaturing PAGE. The lanes marked as total contain 10% of the reaction mixture
used for the sedimentation. The structure of each RNA product is shown schematically on the right. The asterisk indicates the product that is likely
to be produced by aberrant splicing. (C) Immunoprecipitation experiments of the RNAs from the IL complex containing fractions. An in vitro
splicing reaction was performed and either anti-hPrp43 antibody or anti-Flag antibody bound to protein A-Sepharose was used for immunopreci-
pitation from the IL complex enriched fraction of either wild-type FLAG-TFIP11 or FLAG-TFIPN expressing extracts. Co-precipitated RNAs
were analyzed by 6% denaturing PAGE. In the case of mock precipitation (Mock), anti-GST antibody was used. RNA products from 10% of each
reaction were present in the lanes marked as ‘Input’. The schematic representation of each RNA is shown on the right of the panel. (D) Quantitation
of the lariat intron RNA precipitation results shown in (C). Averages and standard deviations obtained from three independent experiments are
shown.
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contained both U5 snRNA and hPrp19 complex proteins.
Thus, it is plausible to hypothesize that U5 snRNP is
released from the IL complex as a form of 35S U5
snRNP (Figure 7). The released 35S U5 snRNP is then
converted to 20S U5 snRNP for the next round splicing
reactions (3).
Interestingly, SF3a/3b proteins, which are components
of 17S U2 snRNP, were barely detected in the puriﬁed IL
complex despite the clear presence of U2 snRNA and
U2B00 core protein (Figure 3B and Figure S1). This
means that the U2 snRNP in the IL complex is in the
12S form. Recently, it has been demonstrated that the
association of SF3a/3b proteins with the spliceosome is
destabilized upon B to C transition (10). Our result that
SF3a/3b proteins are not stable constituents of the IL
complex is consistent with this paper. Taken together,
we believe that U2 snRNP is released from the IL complex
as a form of 12S U2 snRNP (Figure 7).
While a complex containing TFIP11 and hPrp43 is
likely to mediate the IL complex disassembly, our results
also suggest that TFIP11 is a stable constituent of the IL
complex. However, hPrp43 had a peak in #9 fraction,
whereas TFIP11 mainly existed in #8 fraction
(Figure 3B). Thus, it is likely that hPrp43 is not a stable
constituent of IL complex and targets the IL complex only
transiently for the disassembly of the IL complex. This
targeting is probably mediated by its interaction with
the G-patch domain of TFIP11 (Figures 4 and 5).
TFIP11 protein thus acts as a scaﬀold that recruits
hPrp43 protein to the IL complex (Figure 7). However,
the hPrp43 protein is reported to be associated with the B
spliceosome as a part of 17S U2 snRNP (42). Thus,
hPrp43 is thought to be released sometime between the
B and IL complexes. When hPrp43 targets the IL complex
for disassembly, it has to utilize a diﬀerent targeting
system (TFIP11) since U2 snRNP is no longer in its
17S form in the IL complex. Why such a complicated
targeting system is employed is currently unknown. The
resultant IS complex serves as an eﬃcient substrate for
hDBR1 leading to a complete degradation of the intron
(Figure 7).
Figure 6. In vitro debranching assays of the lariat introns from IS and IL complex. (A) The recombinant hDBR1 proteins used for the in vitro
debranching assay. Either Flag vector alone, or plasmids encoding the Flag-hDBR1 wild-type or NA mutant were transfected into HEK293T cells,
and proteins were puriﬁed by anti-Flag M2 resin from whole-cell extracts. Puriﬁed proteins were separated by 5–20% gradient SDS–PAGE and
detected by Coomassie brilliant blue staining. The position of Flag tagged hDBR1 proteins is indicated by an arrow. (B) In vitro debranching assays
of the lariat intron RNAs recovered from IS and IL complexes. In vitro debranching assays with the puriﬁed recombinant Flag-hDBR1 proteins
shown in (A). Lariat intron RNPs recovered from total supernatant. IS and IL complexes were incubated with Flag-DBR1 proteins. After the
reaction, the RNAs were analyzed by 6% denaturing PAGE. The structure of RNAs is demonstrated schematically on the right of the panel.
Figure 7. A model for the intron turnover pathway after splicing in the nucleus. Our model for the post-splicing intron turnover pathway. See text
for details.
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IL complex in this study, the nature of the IS complex is
not well known. In yeast, Ntr1 forms a heterodimer with
Ntr2 and functions as a trimer with Prp43 for the disas-
sembly of the post-splicing complex (17,43). The resultant
disassembled product is thought to be free lariat intron
RNA (17,43). In our case, however, we do not think
that the IS complex is devoid of all factors, although it
is devoid of all the splicing factors tested in this study. The
IS complex migrated as 20S, which is clearly diﬀerent from
the gel-puriﬁed free lariat intron (data not shown). It
should also be pointed out that no human homolog
of Ntr2 has been identiﬁed to date. It is still not clear
whether humans have a counterpart of yeast Ntr2. A
co-immunoprecipitation experiment with TFIP11 may
enable us to identify the candidates for human Ntr2.
In this study, we have focused on the post-splicing com-
plexes of general introns. It is of interest to apply our
puriﬁcation strategy to the isolation of post-splicing com-
plexes of particular introns that harbor noncoding RNAs,
such as snoRNAs and microRNAs. Of these noncoding
RNAs, snoRNAs are known to be produced in coordina-
tion with the splicing process (22). Future experiments
with these speciﬁed pre-mRNAs would help us to gain a
comprehensive understanding of post-splicing intron turn-
over in the nucleus.
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